FE Fundinfo: India, commodities and US dollar high-yield bond funds shine brightest in Q3
European equity funds bruised by global manufacturing slowdown
European equity funds bruised by global manufacturing slowdown
|
|
The new offering aims to outperform the MSCI World Health Care Index
|
|
Stonehage Fleming’s Gerrit Smit discusses the fourth industrial revolution, the reopening of China and currency movements
|
|
Polar Capital’s Deane Donnigan tells Portfolio Adviser how she moved from clinical pharmacist to fund manager
|
|
Manager of the PGIM Jennison Global Equity Opportunities Fund discusses how last year’s valuation reset has created a more fertile hunting ground for equities
|
|
Pictet Positive Change manager Evgenia Molotova and her team look to identify companies with the skill, balance sheet and will to change
|
|
Non-specialist investors flooding into and out of the latest fashionable investment idea can be as much an opportunity as a threat
|
|
The differing attractions of the pioneers, enablers and adopters of genetic sequencing
|
|
Average 12-month share price return of 5.4% masks a significant dispersion
|
|
Paul O’Connor of Janus Henderson and T Rowe Price’s Eric Papesh give their views on the prospects for American assets
|
|
This inherently innovative but sometimes esoteric sector has a lot to offer but market conditions are getting choppy
|
|
Investing through a thematic lens is vital if we are to realise a sustainable world. Portfolio Adviser’s sister publication ESG Clarity talks to experts about the challenges and opportunities in five key areas
|
|